Continua Health Alliance “ Strategic Intelligence Monitor on Personal Health Systems”  Workshop  – IPTS, EC April 2009  Ma...
The Continua Health Alliance Mission
Personal Telehealth Healthy family <ul><li>Health & Wellness </li></ul><ul><li>Weight loss </li></ul><ul><li>Fitness </li>...
Promoter Members Open International
Contributors Over 180 Members! <ul><li>Alcatel Lucent </li></ul><ul><li>Alere </li></ul><ul><li>Allion Test Labs, Inc. </l...
Guidelines    Certification    Recognizable Logo
Version One Design Guidelines 06/24/09 After two years of work from more than 175 companies around the world, Continua Hea...
1 st  Continua Certified Product Congratulations to Nonin Medical, Inc.!
Version One Device Connectivity Standards PC Personal Health System Cell Phone Set Top Box Aggregator Weight Scale Pulse O...
Version One Health Record Standards Home-based Remote Patient Monitoring (RPM) System Vital Sign Devices Patient Electroni...
First Public Interoperability Demonstration Harvard Medical Auditorium 10/27/08 Weighing Scale Wireless Pulse Oximeter Blo...
Ecosystem  Development
Working Group Structure Over 1,400 members participating in the various Working Groups Board Of Directors Use Case WG Tech...
PHS market now and in the future: enablers and drivers
PHS market now and in the future: the perfect storm <ul><li>The challenge: </li></ul><ul><ul><li>In Europe the number of p...
PHS market now and in the future: the potential for transformation <ul><li>The area of telehealth/home health monitoring i...
PHS market now and in the future: the potential for transformation <ul><li>US could generate net savings of  $197 billion ...
PHS market now: actors <ul><li>Continua membership shows across the board interest both from supply and demand sides: </li...
PHS market in the future <ul><li>The individual / home as the hub </li></ul><ul><li>Convergence consumer / healthcare </li...
PHS market in the future:  the continuum of life and care Amateur Athlete Diet/Fitness Focused Worried Well Elderly Living...
<ul><li>Step 1 </li></ul><ul><ul><li>Identify & define modifiable health and standardize it across populations by referenc...
PHS market in the future: disease management The Innovative Care for Chronic Conditions Framework (WHO)
PHS market in the future: disease management Real-time, two way communication Personal Health Systems <ul><li>Vital sign c...
PHS market in the future: ageing independently Global ageing experience project, Intel Feeling safe “ Since I fell I’m a l...
Weight Scale Person Centered Device / Systems / Sensors Biometrics Testing HRA/Health Administrative Assistant  Classes In...
Business cases to follow-up on RPM and disease management {Not comprehensive} <ul><li>England </li></ul><ul><ul><li>Whole ...
Innovation models: some considerations <ul><li>Telehealth </li></ul><ul><ul><li>Moving past initial pilots  requires the c...
Thank You Thank you! [email_address] www.continuaalliance.org
Upcoming SlideShare
Loading in …5
×

Continua Health Alliance

1,875 views

Published on

Vesa Pakarinen's presentation at UBI-SERV Start-up Workshop May 19th 2009 at TKK

Published in: Health & Medicine, Business
0 Comments
1 Like
Statistics
Notes
  • Be the first to comment

No Downloads
Views
Total views
1,875
On SlideShare
0
From Embeds
0
Number of Embeds
19
Actions
Shares
0
Downloads
102
Comments
0
Likes
1
Embeds 0
No embeds

No notes for slide
  • A new low-cost tool now in development has the potential to address these challenges and drive ROI for wellness to new heights. The tool uses minimally invasive technologies, common to the medical community for more than 40 years, to allow employees easy access to their personal biometrics. These personal biometrics are the common metabolic indicators associated with most health problems, including heart disease, diabetes, liver disease, kidney failure, cancer, cognitive decline and more. With objective monitoring of these personal biometrics (referred to as Lifestyle Performance Indicators), an individual’s trend toward disease can be predicted even before onset of symptoms or signs. Frequent and easy access to their own biology will involve employees in evidence-based lifestyle management, encouraging decisions that optimize prevention. How hard can it be to define and track gene expression? If we restrict ourselves to the gene expression that only accounts for many common adverse health outcomes such as heart disease, stroke, diabetes and many cancers, gene expression tracking and modifying may be entirely doable. Here again, recent medical research suggests that the aforementioned list of outcomes are not predated by separated events but that they be the result of metabolic events which share considerable overlap. Progressive Insulin resistance (IR) burden is increasingly associated with multiple adverse health outcomes such as Diabetes[42], Heart Disease[43-51], stroke[52] many cancers[53-59], liver disease, renal failure and cognitive decline[60-63]. Moreover, IR can be tracked using common clinical markers [64-69] . Thus the current Health Risk Assessment (HRA) which relies largely upon self-reported data such as daily minutes spent walking can be upgraded via sensor-based approaches. The pedometer can wirelessly upload objective data regarding number of steps per day and the biological response to said level of activity can be track through changes in IR burden via quarterly home-collection biometric monitoring technology. Perhaps more importantly, these remote technologies will soon spontaneously upload sensor data to Personally Controlled Health Records. Through tracking of periodic health response (IR change) to specific health modifying efforts, individuals will become their own best health advocate. Personal health literacy, health engagement and perception of personal control over health are expected to be greatly enhanced. TM uses a home-collection system to track his lifestyle burden as his brother was diagnosed with Heart Disease 2 years ago. Now he values his continua pedometer and weight scale. TM has determined that he just needs to keep his step# at 12,000/day and his weight below 240 lbs to avoid any deterioration in his modifiable health. TM has self-selected options that would fit his lifestyle. When his “numbers “deteriorate he adds on a Continua stationary bike for an added workout until he is able to “flat line again”.
  • A new low-cost tool now in development has the potential to address these challenges and drive ROI for wellness to new heights. The tool uses minimally invasive technologies, common to the medical community for more than 40 years, to allow employees easy access to their personal biometrics. These personal biometrics are the common metabolic indicators associated with most health problems, including heart disease, diabetes, liver disease, kidney failure, cancer, cognitive decline and more. With objective monitoring of these personal biometrics (referred to as Lifestyle Performance Indicators), an individual’s trend toward disease can be predicted even before onset of symptoms or signs. Frequent and easy access to their own biology will involve employees in evidence-based lifestyle management, encouraging decisions that optimize prevention. How hard can it be to define and track gene expression? If we restrict ourselves to the gene expression that only accounts for many common adverse health outcomes such as heart disease, stroke, diabetes and many cancers, gene expression tracking and modifying may be entirely doable. Here again, recent medical research suggests that the aforementioned list of outcomes are not predated by separated events but that they be the result of metabolic events which share considerable overlap. Progressive Insulin resistance (IR) burden is increasingly associated with multiple adverse health outcomes such as Diabetes[42], Heart Disease[43-51], stroke[52] many cancers[53-59], liver disease, renal failure and cognitive decline[60-63]. Moreover, IR can be tracked using common clinical markers [64-69] . Thus the current Health Risk Assessment (HRA) which relies largely upon self-reported data such as daily minutes spent walking can be upgraded via sensor-based approaches. The pedometer can wirelessly upload objective data regarding number of steps per day and the biological response to said level of activity can be track through changes in IR burden via quarterly home-collection biometric monitoring technology. Perhaps more importantly, these remote technologies will soon spontaneously upload sensor data to Personally Controlled Health Records. Through tracking of periodic health response (IR change) to specific health modifying efforts, individuals will become their own best health advocate. Personal health literacy, health engagement and perception of personal control over health are expected to be greatly enhanced. TM uses a home-collection system to track his lifestyle burden as his brother was diagnosed with Heart Disease 2 years ago. Now he values his continua pedometer and weight scale. TM has determined that he just needs to keep his step# at 12,000/day and his weight below 240 lbs to avoid any deterioration in his modifiable health. TM has self-selected options that would fit his lifestyle. When his “numbers “deteriorate he adds on a Continua stationary bike for an added workout until he is able to “flat line again”.
  • A new low-cost tool now in development has the potential to address these challenges and drive ROI for wellness to new heights. The tool uses minimally invasive technologies, common to the medical community for more than 40 years, to allow employees easy access to their personal biometrics. These personal biometrics are the common metabolic indicators associated with most health problems, including heart disease, diabetes, liver disease, kidney failure, cancer, cognitive decline and more. With objective monitoring of these personal biometrics (referred to as Lifestyle Performance Indicators), an individual’s trend toward disease can be predicted even before onset of symptoms or signs. Frequent and easy access to their own biology will involve employees in evidence-based lifestyle management, encouraging decisions that optimize prevention. How hard can it be to define and track gene expression? If we restrict ourselves to the gene expression that only accounts for many common adverse health outcomes such as heart disease, stroke, diabetes and many cancers, gene expression tracking and modifying may be entirely doable. Here again, recent medical research suggests that the aforementioned list of outcomes are not predated by separated events but that they be the result of metabolic events which share considerable overlap. Progressive Insulin resistance (IR) burden is increasingly associated with multiple adverse health outcomes such as Diabetes[42], Heart Disease[43-51], stroke[52] many cancers[53-59], liver disease, renal failure and cognitive decline[60-63]. Moreover, IR can be tracked using common clinical markers [64-69] . Thus the current Health Risk Assessment (HRA) which relies largely upon self-reported data such as daily minutes spent walking can be upgraded via sensor-based approaches. The pedometer can wirelessly upload objective data regarding number of steps per day and the biological response to said level of activity can be track through changes in IR burden via quarterly home-collection biometric monitoring technology. Perhaps more importantly, these remote technologies will soon spontaneously upload sensor data to Personally Controlled Health Records. Through tracking of periodic health response (IR change) to specific health modifying efforts, individuals will become their own best health advocate. Personal health literacy, health engagement and perception of personal control over health are expected to be greatly enhanced. TM uses a home-collection system to track his lifestyle burden as his brother was diagnosed with Heart Disease 2 years ago. Now he values his continua pedometer and weight scale. TM has determined that he just needs to keep his step# at 12,000/day and his weight below 240 lbs to avoid any deterioration in his modifiable health. TM has self-selected options that would fit his lifestyle. When his “numbers “deteriorate he adds on a Continua stationary bike for an added workout until he is able to “flat line again”.
  • A new low-cost tool now in development has the potential to address these challenges and drive ROI for wellness to new heights. The tool uses minimally invasive technologies, common to the medical community for more than 40 years, to allow employees easy access to their personal biometrics. These personal biometrics are the common metabolic indicators associated with most health problems, including heart disease, diabetes, liver disease, kidney failure, cancer, cognitive decline and more. With objective monitoring of these personal biometrics (referred to as Lifestyle Performance Indicators), an individual’s trend toward disease can be predicted even before onset of symptoms or signs. Frequent and easy access to their own biology will involve employees in evidence-based lifestyle management, encouraging decisions that optimize prevention. How hard can it be to define and track gene expression? If we restrict ourselves to the gene expression that only accounts for many common adverse health outcomes such as heart disease, stroke, diabetes and many cancers, gene expression tracking and modifying may be entirely doable. Here again, recent medical research suggests that the aforementioned list of outcomes are not predated by separated events but that they be the result of metabolic events which share considerable overlap. Progressive Insulin resistance (IR) burden is increasingly associated with multiple adverse health outcomes such as Diabetes[42], Heart Disease[43-51], stroke[52] many cancers[53-59], liver disease, renal failure and cognitive decline[60-63]. Moreover, IR can be tracked using common clinical markers [64-69] . Thus the current Health Risk Assessment (HRA) which relies largely upon self-reported data such as daily minutes spent walking can be upgraded via sensor-based approaches. The pedometer can wirelessly upload objective data regarding number of steps per day and the biological response to said level of activity can be track through changes in IR burden via quarterly home-collection biometric monitoring technology. Perhaps more importantly, these remote technologies will soon spontaneously upload sensor data to Personally Controlled Health Records. Through tracking of periodic health response (IR change) to specific health modifying efforts, individuals will become their own best health advocate. Personal health literacy, health engagement and perception of personal control over health are expected to be greatly enhanced. TM uses a home-collection system to track his lifestyle burden as his brother was diagnosed with Heart Disease 2 years ago. Now he values his continua pedometer and weight scale. TM has determined that he just needs to keep his step# at 12,000/day and his weight below 240 lbs to avoid any deterioration in his modifiable health. TM has self-selected options that would fit his lifestyle. When his “numbers “deteriorate he adds on a Continua stationary bike for an added workout until he is able to “flat line again”.
  • Continua Health Alliance

    1. 1. Continua Health Alliance “ Strategic Intelligence Monitor on Personal Health Systems” Workshop – IPTS, EC April 2009 Mario Romao Co-Chair, EU Policy WG, Continua Health Alliance Senior Manager, Healthcare Policy, Intel Corporation Extended team: Stelios Tsintzos, Medtronic; Brigitte Piniewski, Oregon Medical Laboratories; Luis Perez, Telefonica; Christine Claus, Intel; Petra Wilson, Cisco; Vesa Pakarinen, VTT; Charles Lowe, Telehealth Solutions; Chuck Parker, Continua Health Alliance
    2. 2. The Continua Health Alliance Mission
    3. 3. Personal Telehealth Healthy family <ul><li>Health & Wellness </li></ul><ul><li>Weight loss </li></ul><ul><li>Fitness </li></ul><ul><li>Email / chat / video </li></ul><ul><li>Appt scheduling </li></ul><ul><li>Personal Health Records </li></ul>Internet Weight loss and fitness coaching Healthcare Professionals Personal Health Records <ul><li>Disease Management </li></ul><ul><li>Vital sign monitoring (RPM) </li></ul><ul><li>Medication reminders and compliance </li></ul><ul><li>Trend analysis and alerts </li></ul><ul><li>Connect with family care givers </li></ul><ul><li>Aging Independently </li></ul><ul><li>An adult child helping their elderly parents age gracefully in their own home. </li></ul><ul><li>Basic life monitoring as appropriate (ADL) </li></ul>Elderly Disease management service Family care givers Digital Home Cell Phone PC Personal Health System PEDOMETER BLOOD- PRESSURE CUFF MEDICATION TRACKING HOME AUTOMATION & CONTROL FITNESS EQUIPMENT IMPLANT PULSE OX
    4. 4. Promoter Members Open International
    5. 5. Contributors Over 180 Members! <ul><li>Alcatel Lucent </li></ul><ul><li>Alere </li></ul><ul><li>Allion Test Labs, Inc. </li></ul><ul><li>All Medicus Co., Ltd. </li></ul><ul><li>American Heart Association </li></ul><ul><li>Analog Devices </li></ul><ul><li>Andago Ingenieria s.l. </li></ul><ul><li>AppsHub, Inc. </li></ul><ul><li>AT4 Wireless </li></ul><ul><li>AT&T Mobility </li></ul><ul><li>AViTA </li></ul><ul><li>BiancaMed </li></ul><ul><li>BIOSPACE Co., Ltd. </li></ul><ul><li>Bluegiga Technologies Oy </li></ul><ul><li>Boston Scientific </li></ul><ul><li>Cambridge Consultants Ltd. </li></ul><ul><li>Capital Health </li></ul><ul><li>Card Guard AG </li></ul><ul><li>Cardiff University </li></ul><ul><li>Cardiomedix Inc. </li></ul><ul><li>CELS, Ltd. </li></ul><ul><li>Centre for Global eHealth Innovation </li></ul><ul><li>Cerner Corporation </li></ul><ul><li>Chiptech Limited </li></ul><ul><li>Christus Health </li></ul><ul><li>Chunghwa Telecom Co., Ltd. </li></ul><ul><li>Claricode, Inc. </li></ul><ul><li>Computerized Screening, Inc. </li></ul><ul><li>ConnectBlue AB </li></ul><ul><li>Continuity Health </li></ul><ul><li>Convergence Wireless, Inc. </li></ul><ul><li>CSR plc </li></ul><ul><li>CYPAK AB </li></ul><ul><li>Cypress Semiconductor </li></ul><ul><li>Dell </li></ul><ul><li>Digi International </li></ul><ul><li>Dossia Consortium </li></ul><ul><li>Dovetail Health </li></ul><ul><li>Duodecim Medical Publications </li></ul><ul><li>Dynastream Innovations Inc. </li></ul><ul><li>Ember Corporation </li></ul><ul><li>Empirica GmbH </li></ul><ul><li>Ericsson Nikola Tesla d.d. </li></ul><ul><li>ETRI </li></ul><ul><li>EuroTech, Inc. </li></ul><ul><li>Fairbanks Scales </li></ul><ul><li>FitLinxx </li></ul><ul><li>Foundation for Research and Technology </li></ul><ul><li>France Telecom R&D, LLC </li></ul><ul><li>Freescale Semiconductor </li></ul><ul><li>Frontline Test Equipment </li></ul><ul><li>Fujitsu Limited </li></ul><ul><li>Fullpower Technologies </li></ul><ul><li>GC Healthcare Corp. </li></ul><ul><li>GenerationOne, Inc. </li></ul><ul><li>GlaxoSmithKline </li></ul><ul><li>Google Inc. </li></ul><ul><li>H3System Co. Ltd </li></ul><ul><li>Hitachi, Ltd. </li></ul><ul><li>Home Guardian, LLC </li></ul><ul><li>Honeywell HomMed LLC </li></ul><ul><li>Hosiden Corporation </li></ul><ul><li>Industrial Technology Research Institute </li></ul><ul><li>Infineon Technologies </li></ul><ul><li>INFORSON Co., Ltd. </li></ul><ul><li>Innomed Medical Zrt. </li></ul><ul><li>Institute for Infocomm Research </li></ul><ul><li>Institute of Biomedical </li></ul><ul><li>InterComponentWare, Inc. </li></ul><ul><li>Intramed A/S </li></ul><ul><li>KDDI </li></ul><ul><li>Konami Sports and Life </li></ul><ul><li>Lamprey Networks, Inc. </li></ul><ul><li>LAXTHA Inc. </li></ul><ul><li>LG CNS </li></ul><ul><li>LG Electronics Inc. </li></ul><ul><li>LifeGate, Inc. </li></ul><ul><li>Lifescan </li></ul><ul><li>Logic </li></ul><ul><li>LS Research, LLC </li></ul><ul><li>MEDCEL </li></ul><ul><li>MedHelp International </li></ul><ul><li>Medixine Oy </li></ul><ul><li>MedSignals </li></ul><ul><li>MedTech Systems Inc. </li></ul><ul><li>Microlife Corporation </li></ul><ul><li>Midmark Corporation </li></ul><ul><li>Misys Healthcare Systems </li></ul><ul><li>Monitray, LLC </li></ul><ul><li>Motorola </li></ul><ul><li>MIR- Medical International Research </li></ul><ul><li>Murata Manufacturing Co., Ltd. </li></ul><ul><li>Neusoft Medical Systems </li></ul><ul><li>Nippon Telegraph and Telephone Corporation </li></ul><ul><li>Nitto Denko Corporation </li></ul><ul><li>Novo Nordisk </li></ul><ul><li>Nuubo (Smart Solutions Tech) </li></ul><ul><li>ON Semiconductor </li></ul><ul><li>Oregon Medical Labs </li></ul><ul><li>Oregon Scientific Inc. </li></ul><ul><li>PA Consulting Group </li></ul><ul><li>Pfizer </li></ul><ul><li>Precor Fitness </li></ul><ul><li>Proskauer Rose LLP </li></ul><ul><li>Proteus Biomedical, Inc. </li></ul><ul><li>RMD Networks </li></ul><ul><li>Ryoyo Electro Corporation </li></ul><ul><li>Sensor Technology & Devices Ltd </li></ul><ul><li>Shimmer Research </li></ul><ul><li>SHL Telemedicine </li></ul><ul><li>Shorewood Packaging </li></ul><ul><li>Silicon and Software Systems </li></ul><ul><li>Smartlife Technology Ltd </li></ul><ul><li>Sony Electronics Inc. </li></ul><ul><li>Southern Nevada Wellness </li></ul><ul><li>Stichting IMEC – Nederland </li></ul><ul><li>Stollmann E+V GmbH </li></ul><ul><li>STMicroelectronics </li></ul><ul><li>TaiDoc Technology Corporation </li></ul><ul><li>Tanita Corporation </li></ul><ul><li>TechnoGym </li></ul><ul><li>Tekoa Technologies Inc. </li></ul><ul><li>Telbios, SpA </li></ul><ul><li>Telecom Italia SpA </li></ul><ul><li>Telefonica S.A. </li></ul><ul><li>Telehealth Solutions Ltd. </li></ul><ul><li>Telus Communications Company </li></ul><ul><li>Terumo Corporation </li></ul><ul><li>Textronics Inc. </li></ul><ul><li>The Scottish Centre for Telehealth </li></ul><ul><li>Toshiba Home Appliances Corporation </li></ul><ul><li>Toumaz Technology Limited </li></ul><ul><li>Triage Wireless Inc. </li></ul><ul><li>TSB Soluciones </li></ul><ul><li>TTA </li></ul><ul><li>Tyco Electronics </li></ul><ul><li>Tynetec Ltd </li></ul><ul><li>UnitedHealth Group </li></ul><ul><li>University of Miami - Miller School of Medicine </li></ul><ul><li>Verizon </li></ul><ul><li>VivoMetrics, Inc. </li></ul><ul><li>VTT Technical Research Centre of Finland </li></ul><ul><li>Westchester Institute for Human Development </li></ul><ul><li>Whole Health Management </li></ul><ul><li>Zarlink Semiconductor </li></ul><ul><li>Zensys </li></ul>
    6. 6. Guidelines  Certification  Recognizable Logo
    7. 7. Version One Design Guidelines 06/24/09 After two years of work from more than 175 companies around the world, Continua Health Alliance is proud to announce the formal release of its Version One Design Guidelines and the Continua Certification Program Continua Version One Guidelines
    8. 8. 1 st Continua Certified Product Congratulations to Nonin Medical, Inc.!
    9. 9. Version One Device Connectivity Standards PC Personal Health System Cell Phone Set Top Box Aggregator Weight Scale Pulse Oximeter Independent Living Activity Cardiovascular and Strength Fitness Monitor Medication Monitor Glucose Meter Pulse / Blood Pressure Bluetooth Medical Device Profile Specification USB Personal Healthcare Device Class Specification <ul><li>11073-10404 = Pulse Oximeter </li></ul><ul><li>11073-10406 = Pulse / Heart Rate </li></ul><ul><li>11073-10407 = Blood Pressure </li></ul><ul><li>11073-10408 = Thermometer </li></ul><ul><li>11073-10415 = Weighing Scale </li></ul><ul><li>11073-10417 = Glucose </li></ul><ul><li>11073-10441 = Cardiovascular Fitness Monitor </li></ul><ul><li>11073-10442 = Strength Fitness Equipment </li></ul><ul><li>11073-10471 = Independent Living Activity </li></ul><ul><li>11073-10472 = Medication Monitor </li></ul>
    10. 10. Version One Health Record Standards Home-based Remote Patient Monitoring (RPM) System Vital Sign Devices Patient Electronic Health Record System EHR / PHR Labs Healthcare Provider Disease Management Service XDR Transport Specification CDA/CCD-based Personal Health Monitoring (PHM) Specification
    11. 11. First Public Interoperability Demonstration Harvard Medical Auditorium 10/27/08 Weighing Scale Wireless Pulse Oximeter Blood Pressure Monitor Device Interface XHR Interface EHR Heart Failure & COPD EHR PHR Telehealth Service Telehealth Service Telehealth Service Obesity & Diabetes
    12. 12. Ecosystem Development
    13. 13. Working Group Structure Over 1,400 members participating in the various Working Groups Board Of Directors Use Case WG Technical WG Test & Certification WG Employer HR Benefits WG VTM Administration Expert Group NHS, AAFP, ATA, AHA… Sub- Committees PR & Marketing agency Marketing WG Regulatory WG Policy Strategy WG Australia Policy WG EU Policy WG Japan Policy WG Latin America Policy WG U.S. Policy WG U.S. Payer WG Executive Director
    14. 14. PHS market now and in the future: enablers and drivers
    15. 15. PHS market now and in the future: the perfect storm <ul><li>The challenge: </li></ul><ul><ul><li>In Europe the number of people aged from 65 to 80 will rise by nearly 40% between 2010 and 2030, and by 2050 more than a quarter of the European population is expected to be over 65 years ( EC, WHO ) </li></ul></ul><ul><ul><li>In England 15.4 million people, including 60 percent of those over age 60, suffer from a long-term condition. LTCs account for 72 percent of all inpatient bed days, 65 percent of all outpatient appointments and 52 percent of all GP appointments. LTCs consume 69 percent of England’s primary and acute care budget ( NHS England ) </li></ul></ul><ul><ul><li>In 2005, 12 percent of the total workforce in the Netherlands worked in the (health)care sector. This percentage should become 25 %, to fulfill the need in 2025. ( Goudriaan et al, 2005 ). </li></ul></ul><ul><ul><li>Almost half of all Americans – 133 million people in 2005 – have at least one chronic condition, and the medical care costs of people with chronic diseases consumes more than 75 percent of US medical care costs ( CDC ) </li></ul></ul><ul><ul><li>… etc… </li></ul></ul>
    16. 16. PHS market now and in the future: the potential for transformation <ul><li>The area of telehealth/home health monitoring is predicted to grow very rapidly, from a $3B market in 2009 in North America and Europe to an estimated $7.7B in 2012 ( Data Monitor, 2007 ) </li></ul><ul><li>Number of telehealth subscribers worldwide will increase to 55.5 million by 2016, representing a forecast CAGR of almost 72%, (InMedica, 2008) </li></ul><ul><li>There is increasing evidence to support the value of remote monitoring for patients with chronic diseases, including: </li></ul><ul><ul><li>35-56% reduction in mortality ; </li></ul></ul><ul><ul><li>47% reduction in risk of hospitalization; </li></ul></ul><ul><ul><li>6 days reduction in length of hospital admission and </li></ul></ul><ul><ul><li>65% reduction in office visits ; </li></ul></ul><ul><ul><li>40-64% reduction in physician time for checks and </li></ul></ul><ul><ul><li>63% reduction in transport costs </li></ul></ul><ul><li>( Cleland et al 2005; Lee R, Goldberg et al, 2003; Scalvini S et al., 2001; Elsner et al, 2006; Van Ginneken et al 2006 ) </li></ul>
    17. 17. PHS market now and in the future: the potential for transformation <ul><li>US could generate net savings of $197 billion dollars over 25 years through telehealth-enabled monitoring of patients with CHF, diabetes, COPD, and chronic skin ulcers ( Litan, 2008 ) </li></ul><ul><li>US Veterans Administration: over a four year period, more than 30,000 patients enrolled in the VA’s remote monitoring program showed a 19.74% decrease in hospital admissions and 25.31% reduction in BDOC (Darkins et al, 2008) </li></ul><ul><li>The focus on wellness : </li></ul><ul><ul><li>Poor health lifestyles dramatically increase population risk for disease; </li></ul></ul><ul><ul><li>The costs of waiting to intervene until after disease is present are staggering; </li></ul></ul><ul><ul><li>Low risk populations can remain healthy by modifying personal health behaviours; </li></ul></ul><ul><li>F. Wang et al, 2004; B. Piniewski,2006; L. Yen et al.,2006; D.W. Edington, 2008; C. Herman et al.,2006 </li></ul>
    18. 18. PHS market now: actors <ul><li>Continua membership shows across the board interest both from supply and demand sides: </li></ul><ul><ul><li>Medical devices </li></ul></ul><ul><ul><li>Fitness </li></ul></ul><ul><ul><li>IT </li></ul></ul><ul><ul><li>Pharma </li></ul></ul><ul><ul><li>Health care providers </li></ul></ul><ul><ul><li>Health insurers </li></ul></ul><ul><ul><li>Telecommunications </li></ul></ul><ul><ul><li>Sensors </li></ul></ul><ul><ul><li>Internet </li></ul></ul><ul><ul><li>Applications (PHR, EHR, desktop) </li></ul></ul>
    19. 19. PHS market in the future <ul><li>The individual / home as the hub </li></ul><ul><li>Convergence consumer / healthcare </li></ul><ul><li>Consumer health / PHRs fitness - sometimes with public incentives </li></ul><ul><li>Support public health and corporate wellness programs </li></ul><ul><li>Rewards for keeping people healthy </li></ul><ul><li>Greater integration among wellness, health and social care </li></ul><ul><li>Best-of-breed plug and play </li></ul><ul><li>Increased connectivity, evolutionary, scalable, service driven offerings </li></ul>
    20. 20. PHS market in the future: the continuum of life and care Amateur Athlete Diet/Fitness Focused Worried Well Elderly Living Independently Chronic Patient Acute Recovery Infant CONTINUUM of LIFE CONTINUUM of CARE GIVERS Doctor/NP/Nurse Home Nursing Professional The Family Fitness Wellness Coach New Parents The Continua Health Alliance “connected health and care” vision blurs the frontiers across solutions for healthcare, wellness and ageing independently. The individual truly becomes the hub for wellness and health management.
    21. 21. <ul><li>Step 1 </li></ul><ul><ul><li>Identify & define modifiable health and standardize it across populations by referencing health to an indicator such as TCHOL/HDL </li></ul></ul><ul><li>Step 2 </li></ul><ul><ul><li>Move from self-reported data to a sensor-based approach that wirelessly uploads objective data to track Lifestyle Performance Indicator responses to specific health modifying efforts </li></ul></ul><ul><li>Step 3 </li></ul><ul><ul><li>Objectively monitor Lifestyle Performance Indicators to predict an individual’s trend toward disease before onset of symptoms or signs and associated costs </li></ul></ul>PHS market in the future: public health and employer programs Lifestyle Burden Heart Disease Stroke Diabetes Alzheimer's D Kidney Failure Liver Disease Many Cancers Cognitive Decline Lifestyle Performance Indicators Triglycerides (TG) High Density Lipoproteins (HDL) TG/HDL Low Density Lipoproteins (LDL) Total Cholesterol (TCHOL) TCHOL/HDL Insulin Glucose Disease Pre-Disease
    22. 22. PHS market in the future: disease management The Innovative Care for Chronic Conditions Framework (WHO)
    23. 23. PHS market in the future: disease management Real-time, two way communication Personal Health Systems <ul><li>Vital sign collection and management </li></ul><ul><li>Integration with: </li></ul><ul><ul><li>survey results </li></ul></ul><ul><ul><li>educational content </li></ul></ul><ul><ul><li>video conferencing </li></ul></ul><ul><li>Data rich health management systems </li></ul><ul><li>Connection to: </li></ul><ul><ul><li>friends and caregivers </li></ul></ul><ul><ul><li>healthcare advice and information </li></ul></ul><ul><li>Safe and friendly environment </li></ul>adapted from Intel Community partners Health care team Patients and families prepared informed motivated Improved quality of care and Social connection Greater information sharing ICCC, WHO
    24. 24. PHS market in the future: ageing independently Global ageing experience project, Intel Feeling safe “ Since I fell I’m a lot more afraid of falling” Supporting cognition “ You have to challenge your mind and brain” Supporting physical activities “ I want to move easily, be independent” Bringing healthcare home “ People think that doctors can cure everything- that’s not true” Help getting care “ We know the pharmacist very well, it’s easy to get my medicine” Enabling social interaction “ I don’t like to be alone” Meaningful & useful life “ It would be great to maybe have an exhibition of my work sometime” Environments of choice “ Despite my lack of mobility I can turn on garden lights with this remote control” THE MIND-BODY CONTINUUM <ul><li>Connected PHS ecosystems enabling: </li></ul><ul><li>Basic ADL monitoring </li></ul><ul><li>Health information </li></ul><ul><li>Disease management </li></ul><ul><li>Social interaction </li></ul><ul><li>Beyond home support </li></ul><ul><li>Virtual residential care homes </li></ul>
    25. 25. Weight Scale Person Centered Device / Systems / Sensors Biometrics Testing HRA/Health Administrative Assistant Classes Information Systems Fitness Equipment Wellness Management/Support Systems Blood-Presser Cuff Glucose Meter Spirometer Pulse Oximeter Medication Tracking Pedometer Cholesterol HDL/LDL Weight Blood-Pressure Blood Sugar Resting Heart Rate Lung Air Volume Triglycerides Body Fat % Body Fat Analyzer Bio-metric/ Behavioral Responses Multiple providers / service oriented Wellness Center PHR/PHA Fitness, nutrition, stress management… PHS market in the future: the coalescence of market segments Activity Hub Family care givers Elderly monitoring services Disease managementservice Healthcareprovider Gait analysis
    26. 26. Business cases to follow-up on RPM and disease management {Not comprehensive} <ul><li>England </li></ul><ul><ul><li>Whole system demonstrators (three sites: Cornwall, Newham, Kent); 6,000 users; telehealth and telecare </li></ul></ul><ul><li>Northern Ireland </li></ul><ul><ul><li>Implementation of RPM covering 5,000 users </li></ul></ul><ul><li>West Lothian </li></ul><ul><ul><li>Implementation of RPM covering 400 users </li></ul></ul><ul><li>AOK, Deutsche BKK </li></ul><ul><ul><li>German statutory health insurers covering heart disease </li></ul></ul><ul><li>Veterans Health Administration (US) </li></ul><ul><ul><li>30,000 users covering multiple diseases </li></ul></ul>
    27. 27. Innovation models: some considerations <ul><li>Telehealth </li></ul><ul><ul><li>Moving past initial pilots requires the creation of a shared vision and belief in the impact of telehealth, training and education support for nurses, patients and carers, and access to secure funding streams/reimbursement models. </li></ul></ul><ul><ul><li>The implementation of telehealth is likely to require a significant change in working practice and training on its use. </li></ul></ul><ul><ul><li>There may be an initial increase in workload and transition period before it is integrated into practice and the benefits realised. </li></ul></ul><ul><ul><li>It is recommended that there are change management tools developed to support this transition </li></ul></ul><ul><ul><li>There should be appropriate training and education for healthcare professionals as part of their continued professional development). </li></ul></ul><ul><ul><li>As with most new innovations champions should be appointed to ensure that projects are driven through. Additionally, identifying “super users” and early adopters to raise awareness of technology and associated benefits can help to drive innovation at all levels of the organisation . </li></ul></ul>
    28. 28. Thank You Thank you! [email_address] www.continuaalliance.org

    ×